Table 4.
Independent Predictors of Recurrent AF After Catheter Ablation by Multivariate Logistic Regression
| OR | 95% CI | |
|---|---|---|
| MRproANP*, per unit | 1.01 | 1.01–1.02 |
| sST2, per unit | 1.01 | 0.98–1.05 |
| Hypertension | 1.78 | 0.47–6.71 |
| Coronary artery disease | 5.40 | 0.76–38.17 |
| CHA2DS2VASC≥2 | 0.98 | 0.21–4.45 |
| LA area>22 cm2 | 2.69 | 0.71–10.14 |
| Diabetes mellitus | 1.28 | 0.28–5.92 |
| LVH | 0.35 | 0.02–6.70 |
| Type of AF at inclusion | 2.00 | 0.93–4.26 |
| Rhythm control therapy at inclusion | 0.45 | 0.14–1.46 |
| LVEF, per unit | 1.03 | 0.96–1.11 |
AF indicates atrial fibrillation; LA, left atrium; LVEF, left ventricular ejection fraction; LVH, left ventricular hypertrophy; MRproANP, midregional N‐terminal pro–atrial natriuretic peptide; OR, odds ratio; and sST2, soluble suppression of tumorigenicity 2.
*
Measured in peripheral venous blood.